Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

VERION Versus Conventional, Manual Ink-marking in Toric IOL Implantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02370953
Recruitment Status : Completed
First Posted : February 25, 2015
Last Update Posted : March 16, 2016
Sponsor:
Information provided by (Responsible Party):
Maastricht University Medical Center

Brief Summary:

OVERVIEW Cataract is a clouding of the crystalline lens which causes vision loss and blindness if untreated. Cataract surgery is the most frequently performed surgical intervention in medicine with an incidence of 880 surgeries per 100.000 population in 2010 amounting to a total number of over 160.000 surgeries per year in the Netherlands.

Approximately 22% of patients with cataract have a substantial pre-existing corneal astigmatism. Toric IOLs provide the opportunity to correct pre-existing astigmatism, offering the patients optimum distance vision without the use of spectacles or contact lenses. Toric IOLs are increasingly used in cataract and refractive surgery.

Since the introduction of toric intraocular lenses (IOLs) in the treatment of cataract in patients with pre-existing corneal astigmatism, numerous studies have shown the importance of accurate positioning of the toric IOL to the intended alignment axis. An error of 5º in toric IOL alignment will decrease the anticipated effect by 17% and thus misalignment will decrease the effectiveness of the astigmatism treatment. There are several methods used to align the toric IOL at the intended axis. Most of these use a 3-step ink-marking procedure and are performed manually. Clinical study showed an average error of 5º in toric IOL alignment when using this method.

Two new tools that have recently been introduced to the market are the VERION Measurement Module and VERION Digital Marker. Together, these tools provide integrated digital guidance for alignment of toric IOLs and they have the potential to eliminate the error in horizontal axis marking and the alignment axis marking error. This will lead to an improved visual outcome. So far, there are no published studies using the VERION tools for toric IOL alignment in cataract surgery. Therefore, the investigators will perform this randomized control trial.

MAIN HYPOTHESIS

The investigators hypothesise that cataract surgery with the implantation of a toric IOL, when using the VERION-tools, compared to manual ink-marking, in patients with corneal astigmatism will lead to:

- An increase in accuracy in toric IOL alignment

OBJECTIVES

Primary Objective:

The primary objective of the study is to compare the accuracy in toric IOL alignment when using the VERION-tools for alignment of the toric IOL or the conventional manual ink-marking procedure.

Other hypotheses and objectives are available in the detailed description.


Condition or disease Intervention/treatment Phase
Astigmatism Device: VERION for toric IOL alignment Procedure: Conventional, manual ink-marking for toric IOL alignment Not Applicable

Detailed Description:

Extra hypotheses

  • A decrease in residual astigmatism
  • An improved best corrected distance visual acuity (BCVA)
  • An improved uncorrected distance visual acuity (UCVA)
  • A decrease in residual refractive astigmatism
  • A decrease or comparable complication profile

Secondary Objective:

The secondary objective of the study is to compare residual astigmatism when using the VERION Measurement Module and VERION Digital Marker for alignment of the toric IOL or the conventional manual ink-marking procedure.

Other Secondary Objectives:

The other secondary objectives are to compare:

  1. Best corrected distance visual acuity (BCVA)
  2. Uncorrected distance visual acuity (UCVA)
  3. Residual refractive astigmatism
  4. Wavefront aberrations
  5. Complication profile

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 34 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: VERION Versus Conventional, Manual Ink-marking in Toric IOL Implantation
Study Start Date : May 2015
Actual Primary Completion Date : January 2016
Actual Study Completion Date : February 2016

Arm Intervention/treatment
Experimental: VERION
In this group the VERION-tools (Digital Marker) are used for the alignment of the toric IOL
Device: VERION for toric IOL alignment
The VERION Measurement Module is a diagnostic device which can make high resolution colour reference images of the patient's eye for position reference. The VERION Digital Marker is a medical device that assists the surgeon in planning and performing surgical procedures on the eye. The VERION tools use several reference points on the conjunctiva and limbus, and make an overlay between the preoperative achieved and live-surgery image. During surgery, this device projects the horizontal axis and the estimated placement axis of the toric IOL on the patient's eye, and therefore, the surgeon can accurately place the toric IOL to its preoperatively calculated angle.
Other Name: VERION Measurement Module and Digital Marker

Active Comparator: Conventional, manual ink-marking
In the group the conventional manual marking is used for the alignment of the toric IOL
Procedure: Conventional, manual ink-marking for toric IOL alignment
Several manually performed methods are used to align the toric IOL at the intended axis. Most of them use a 3-step procedure. First, the horizontal axis of the eye is temporarily marked with ink in a seated position to correct for cyclotorsion when changing into supine position. Three spots on the conjunctiva, close to the edge of the cornea, are applied at 0°, 90° and 180°, which may be done by using a bubblemarker or gravity marker with a calibrated horizontal position. Next, the desired alignment axis for the toric IOL is marked intra-operatively. The last step is to rotate the implanted toric IOL until the IOL markings agree with the alignment marks. After surgery is performed, the ink marks will disappear within a few hours.
Other Name: Conventional, manual ink-marking




Primary Outcome Measures :
  1. Average error (in degrees) in toric IOL-axis [ Time Frame: at week 13 (after the first surgery, if bilateral surgery was performed). ]

Secondary Outcome Measures :
  1. Percentage of eyes with residual refractive cylinder ≤0.5D [ Time Frame: at week 13 (after the first surgery, if bilateral surgery was performed). ]

Other Outcome Measures:
  1. Best corrected distance visual acuity (BCVA) [ Time Frame: at week 13 (after the first surgery, if bilateral surgery was performed). ]
  2. Uncorrected distance visual acuity (UCVA) [ Time Frame: at week 13 (after the first surgery, if bilateral surgery was performed). ]
  3. Residual refractive astigmatism [ Time Frame: at week 13 (after the first surgery, if bilateral surgery was performed). ]
  4. Complication profile [ Time Frame: at week 13 (after the first surgery, if bilateral surgery was performed). ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Astigmatism (at least 1.25D)
  • Cataract
  • Are at least 18 years of age
  • Eye eligible to undergo cataract extraction
  • Eye eligible for toric IOL implantation
  • Bilateral eyes: availability to undergo second eye surgery within 2 weeks of the first eye surgery
  • Willing and able to comply with scheduled visits and other study procedures
  • Understand and signed informed consent

Exclusion Criteria:

  • Irregular corneal astigmatism or keratoconus
  • Extensive age related macular degeneration (atrophic or exudative AMD or numerous soft drusen)
  • Fuchs endothelial dystrophy (stage 2)
  • Uncontrolled/manifest glaucoma
  • Glaucoma related extensive visual field loss
  • Extensive diabetic macular disease
  • Previous intraocular or corneal surgery of any kind
  • Subjects presenting any contraindications to cataract surgery
  • Subjects with a recurrent or active ocular or uncontrolled eyelid disease
  • Subjects with a history of lens instability (e.g. posterior polar cataract, traumatic cataract) or zonular instability

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02370953


Locations
Layout table for location information
Netherlands
Maastricht University Medical Centre
Maastricht, Limburg, Netherlands, 6202 AZ
Sponsors and Collaborators
Maastricht University Medical Center
Investigators
Layout table for investigator information
Principal Investigator: Rudy Nuijts, MD, PhD Maastricht University Hospital

Publications of Results:
Other Publications:
Layout table for additonal information
Responsible Party: Maastricht University Medical Center
ClinicalTrials.gov Identifier: NCT02370953     History of Changes
Other Study ID Numbers: NL51895.068.14
First Posted: February 25, 2015    Key Record Dates
Last Update Posted: March 16, 2016
Last Verified: November 2015

Keywords provided by Maastricht University Medical Center:
Toric IOL alignment
VERION digital marker
Manual ink-marking
Randomized controlled trial

Additional relevant MeSH terms:
Layout table for MeSH terms
Astigmatism
Refractive Errors
Eye Diseases